Canopy Growth Corporation (CGC)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$1.17
-2.92%
Mkt Cap $532.16M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 6, 2026 | $51.59M | $54.28M | +5.21% | -$0.03 | -$0.10 | -233.33% | — | — |
| Q4 2025 Nov 7, 2025 | $71.00M | $66.68M | -6.08% | -$0.11 | -$0.01 | +90.91% | — | — |
| Q3 2025 Aug 8, 2025 | $69.60M | $52.75M | -24.21% | -$0.15 | -$0.14 | +6.67% | — | — |
| Q2 2025 May 30, 2025 | $67.08M | $44.51M | -33.65% | -$0.10 | -$0.94 | -840.00% | — | — |
| Q1 2025 Feb 7, 2025 | $72.00M | $51.92M | -27.89% | -$0.38 | -$0.76 | -100.00% | — | — |
| Q4 2024 Nov 8, 2024 | $47.23M | $46.55M | -1.43% | -$0.38 | -$0.95 | -150.00% | — | — |
| Q3 2024 Aug 9, 2024 | $50.66M | $48.40M | -4.47% | -$0.31 | -$0.37 | -19.35% | — | — |
| Q2 2024 May 30, 2024 | $53.06M | $53.60M | +1.02% | -$0.33 | -$0.28 | +15.15% | — | — |
| Q1 2024 Feb 9, 2024 | $53.08M | $59.11M | +11.36% | -$0.45 | -$1.79 | -297.78% | — | — |
| Q4 2023 Nov 9, 2023 | $68.05M | $51.38M | -24.50% | -$1.20 | -$1.80 | -50.00% | — | — |
| Q3 2023 Aug 9, 2023 | $68.14M | $82.08M | +20.45% | -$1.00 | -$0.40 | +60.00% | — | — |
| Q2 2023 May 26, 2023 | $69.95M | $64.69M | -7.52% | -$0.15 | -$0.42 | -180.00% | — | — |
| Q1 2023 Feb 9, 2023 | $86.26M | $75.43M | -12.55% | -$1.30 | -$3.50 | -169.23% | — | — |
| Q4 2022 Nov 9, 2022 | $81.77M | $86.07M | +5.26% | -$1.80 | -$2.80 | -55.56% | — | — |
| Q3 2022 Aug 5, 2022 | $87.49M | $85.49M | -2.29% | -$2.00 | -$7.00 | -250.00% | — | — |
| Q2 2022 May 27, 2022 | $103.85M | $89.40M | -13.91% | -$2.40 | -$4.20 | -75.00% | — | — |
| Q1 2022 Feb 9, 2022 | $107.43M | $110.55M | +2.91% | -$2.30 | -$2.20 | +4.35% | — | — |
| Q4 2021 Nov 5, 2021 | $222.56M | $103.63M | -53.44% | -$1.40 | -$3.90 | -178.57% | — | — |
| Q3 2021 Aug 6, 2021 | $174.04M | $109.89M | -36.86% | -$1.80 | -$1.30 | +27.78% | — | — |
| Q1 2021 Mar 31, 2021 | — | $118.10M | — | — | -$1.47 | — | — | — |